Drugs / autologous cord blood stem cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02881970 | Feb 2020 → Apr 2028 expected | brain hypoxia - ischemia | Assistance Publique Hopitaux De Marseille | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous cord blood stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02881970 ↗ |
| Modality | Cell therapy | “Cord blood stem cells are a promising treatment for the near future.” NCT02881970 ↗ |